BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
First published online October 26, 2006
British Journal of Radiology (2007) 80, 347-354
© 2007 British Institute of Radiology
doi: 10.1259/bjr/65349468
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narayana, A
Right arrow Articles by Gutin, P H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Narayana, A
Right arrow Articles by Gutin, P H

Full paper

Use of MR spectroscopy and functional imaging in the treatment planning of gliomas

A Narayana, MD 1 J Chang, PhD 2 S Thakur, PhD 2 W Huang, PhD 2,3 S Karimi, MD 3 B Hou, PhD 2,3 A Kowalski, MS 2 G Perera, MS 2 A Holodny, MD 3 and P H Gutin, MD 4,5

Departments of 1 Radiation Oncology, 2 Medical Physics, 3 Radiology and 4 Surgery, Memorial Sloan-Kettering Cancer Center and 5 Department of Neuro-Surgery, Weill Medical College of Cornell University, 1275 York Avenue, New York, NY 10021, USA

Correspondence: Ashwatha Narayana, Department of Radiation Oncology, New York University Medical Center, 550, 1st Avenue, New York, NY 11016, USA. E-mail: ashwatha.narayana{at}nyumc.org

Routine anatomical imaging with CT and MRI does not reliably indicate the true extent or the most malignant areas of gliomas and cannot identify the functionally critical parts of the brain. The aim of the study was to see if the use of MR spectroscopic imaging (MRSI) along with functional MRI (fMRI) can better define both the target and the critical structures to be avoided to improve radiation delivery in gliomas. 12 patients with gliomas underwent multivoxel MRS and functional imaging using GE processing software. The choline to creatine ratio (Cho:Cr), which represents the degree of abnormality for each individual voxel on MRSI, was derived, converted into a grayscale grading system, fused to the MRI images and then transferred to the planning CT images. An intensity-modulated radiation therapy (IMRT) plan was developed using the dose constraints based on both the anatomical and the functionally critical regions. Cho:Cr consistently identified the gross tumour volume (GTV) within the microscopic disease (clinical target volume, CTV) and allowed dose painting using IMRT. No correlation between MRSI based Cho:Cr ≥2 and MR defined CTV nor their location was noted. However, MRSI defined Cho:Cr ≥3 was smaller by 40% compared with post-contrast T1 weighted MRI defined GTV volumes. fMRI helped in optimizing the orientation of the beams. In conclusion, both MRSI and fMRI provide additional information to conventional imaging that may guide dose painting in treatment planning of gliomas. A Phase I IMRT dose intensification trial in gliomas using this information is planned.




This article has been cited by other articles:


Home page
 J Child NeurolHome page
L.-G. Vezina
Imaging of Central Nervous System Tumors in Children: Advances and Limitations
J Child Neurol, October 1, 2008; 23(10): 1128 - 1135.
[Abstract] [PDF]

Home page
 JNMHome page
C. Plathow and W. A. Weber
Tumor Cell Metabolism Imaging
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 43S - 63S.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
BJR review of the year -- 2007
Br. J. Radiol., April 1, 2008; 81(964): 265 - 269.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2007 by the British Institute of Radiology.